Lauren Biscaldi - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Lauren Biscaldi's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Lauren Biscaldi
Verified
Lead Editor, Publications, The Michael J. Fox Foundation for Parkinson's Research
New Jersey, New York
Beats
Healthcare , Life Sciences , Pharmacy , Primary Care , Healthcare Policy , Dermatology , Oncology , Infectious Diseases, Healthcare , Life Sciences , Pharmacy , Primary Care , Healthcare Policy , Dermatology , Oncology , Infectious Diseases, Healthcare , Life Sciences , Pharmacy , Primary Care , Healthcare Policy , Dermatology , Oncology , Infectious Diseases, Healthcare , Life Sciences , Pharmacy , Primary Care , Healthcare Policy , Dermatology , Oncology , Infectious Diseases
Legal, Accounting, Medical, Political, High-tech, Crypto
Content
By Lauren Biscaldi| Drug Topics Verified The last year was a challenging one for pharmacists, who began the year facing cash flow challenges and a DIR hangover and ended it with pharmacy benefit manager (PBM) reform being cut from federal legislation. Between these bookends was the closure of more than 2200 pharmacies, which led to the creation of new health care deserts across the US.1But the news wasn’t all bad: Across the country, more than 100 state-level bills were introduced, many of which expanded pharmacists’ scope of practice.
By Lauren Biscaldi| Drug Topics Verified Another new year means another update to the CDC’s Advisory Committee on Immunization Practices (ACIP) immunization schedules.1 In 2024, ACIP made a number of changes to vaccine recommendations, including a new 21-valent pneumococcal conjugate vaccine, new respiratory syncytial virus vaccines for adults and pregnant women, and more. The following tables have been created using the CDC’s recommended immunization schedules for 2025.
Company Info
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease. Founded by actor Michael J. Fox, who was diagnosed with the disease in 1991, the foundation focuses on accelerating research and improving the lives of those affected. It employs a comprehensive approach that includes funding promising research projects, supporting innovative science, and developing essential research tools. Key initiatives include the Parkinson's Progression Markers Initiative, which gathers data from thousands of volunteers to understand disease progression, and Fox Insight, the largest clinical study involving over 30,000 participants. The foundation also offers the Fox Trial Finder, an online tool that connects volunteers with research studies, and engages in community outreach and educational programs to train the next generation of specialists. Through strategic funding and collaborative partnerships, the foundation plays a vital role in advancing Parkinson's research and supporting the global Parkinson's community.
New York, New York, United States
'+1 800-708-7644
Founded: 2000